PubRank

F Oberling

Author PubWeight™ 65.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981 4.25
2 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study. Ann Oncol 1996 3.10
3 An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther 1996 1.75
4 Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer. Eur J Cancer Clin Oncol 1988 1.52
5 Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. J Infect Dis 1981 1.27
6 Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 1996 1.26
7 Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases. Blut 1976 1.25
8 Treatment of acquired C1-inhibitor deficiency with danazol. Ann Intern Med 1977 1.07
9 Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy 1993 1.02
10 Bone marrow necrosis. acute microcirculation failure in myelomonocytic leukemia. Arch Intern Med 1978 1.02
11 Mixed-lymphocyte reaction as assay for immunological competence of lymphocytes from patients with hodgkin's disease. Lancet 1972 0.98
12 Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol Methods 1991 0.96
13 [Trichosporon capitatum septicemia in immunosuppressed patients]. Pathol Biol (Paris) 1990 0.95
14 Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant 1990 0.95
15 E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival. Invasion Metastasis 1996 0.93
16 Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients. Bone Marrow Transplant 1989 0.92
17 [Application of cytochemical methods to 47 cases of acute leukemia. Cytochemical chages during development]. Sem Hop 1973 0.91
18 Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. J Immunol 1998 0.91
19 Human resident peritoneal macrophages: phenotype and biology. Br J Haematol 1994 0.90
20 Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer. Cancer 1988 0.87
21 Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study. Ann Oncol 1992 0.87
22 CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clin Exp Metastasis 1996 0.87
23 [Letter: Elevation of the absolute number of T-lymphocytes in chronic lymphocytic leukemia]. Nouv Presse Med 1975 0.86
24 Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease. Clin Immunol Immunopathol 1983 0.84
25 Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease. Biomedicine 1974 0.84
26 Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis. Anticancer Drugs 1995 0.83
27 Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia. DNA Cell Biol 1993 0.83
28 [Pseudolymphoma of the stomach. Histological study apropos of 24 cases]. Ann Anat Pathol (Paris) 1966 0.83
29 Acute myeloid leukemia complicating sarcoidosis. J R Soc Med 1992 0.83
30 [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan]. Arch Anat Pathol (Paris) 1972 0.82
31 Immunomodulation with diethyldithiocarbamate in patients with AIDS-related complex. Lancet 1985 0.82
32 Long-term hypokalemia in acute myeloid leukemia. Arch Intern Med 1978 0.82
33 Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission. Cancer 1994 0.81
34 Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 1995 0.81
35 Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP. Exp Hematol 1994 0.80
36 [Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation]. Agressologie 1992 0.80
37 [Acquired C1-esterase inhibitor deficiencies during lymphoid syndromes]. Nouv Presse Med 1975 0.80
38 Depressed NK cell activity of peripheral blood mononuclear cells in untreated hodgkin's disease: enhancing effect of interferon in vitro. Scand J Haematol 1984 0.80
39 Intra-abdominal localization of acute leukaemia: report of six cases. Nouv Rev Fr Hematol 1995 0.80
40 [Treatment by immunosuppressive agents of hemorrhagic and purulent rectocolitis. Possible role of lymphocytes]. Presse Med 1969 0.79
41 [The EEG of sleeping cardiac patients]. Electroencephalogr Clin Neurophysiol 1967 0.79
42 [Isolation of blast-cells from leukemic bone marrow by Isopague-Ficoll density gradient centrifugation]. Pathol Biol (Paris) 1972 0.79
43 U937 cell line: impact of CSFs, IL-6 and IFN-gamma on the differentiation and the Leu-CAM proteins expression. Exp Hematol 1993 0.79
44 Synthesis of complement components C2 and C4 by human monocyte-derived macrophages during in vitro differentiation in serum-free culture conditions. Pathobiology 1991 0.79
45 Auto-immunity in primary myelofibrosis. Biomedicine 1976 0.79
46 Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy. Clin Exp Immunol 1979 0.79
47 Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association. Nouv Rev Fr Hematol 1992 0.79
48 Experimental bone marrow fat necrosis. Virchows Arch A Pathol Anat Histol 1977 0.78
49 [Association of Pick-Herxheimer disease and malignant hemopathies. Apropos of 2 cases]. Ann Dermatol Venereol 1980 0.78
50 Taxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: an interim analysis of a phase II multicenter study. Ann Oncol 1994 0.78
51 Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin and complement abnormalities. Scand J Haematol 1975 0.78
52 Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies. J Biomed Mater Res 1990 0.77
53 Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. Nouv Rev Fr Hematol 1991 0.77
54 Autophagia in myeloid precursors: an explanation for neutropenia in Chediak-Higashi syndrome? Scand J Haematol 1976 0.77
55 Immunophenotypic characterisation of human peritoneal and alveolar macrophages and of human blood monocytes differentiated in the presence of either GM-CSF or M-CSF or a combination of GM-CSF/M-CSF. Nouv Rev Fr Hematol 1992 0.77
56 High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France. Bone Marrow Transplant 1990 0.77
57 [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment]. Nouv Rev Fr Hematol 1984 0.76
58 CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas. Breast Cancer Res Treat 1997 0.76
59 [Hyperuricemia resistant to urate oxidase. Role of anti-serum urate oxidase precipitating antibodies]. Presse Med 1984 0.76
60 "False positive" acidified serum test in a preleukemic dyserythropoiesis. Acta Haematol 1978 0.76
61 Continuous intrathecal perfusion of methotrexate for carcinomatous meningitis with pharmacokinetic studies: two case studies. Clin Oncol (R Coll Radiol) 1997 0.76
62 Human blood-derived macrophages: differentiation in vitro of a large quantity of cells in serum-free medium. Exp Hematol 1992 0.76
63 Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995 0.76
64 Cisplatin-induced anemia: a potential interference with iron metabolism at erythroid progenitors level. Anticancer Drugs 1990 0.76
65 Polyethylenimine-mediated transfection of human monocytes with the IFN-gamma gene: an approach for cancer adoptive immunotherapy. Gene Ther 1998 0.76
66 Hairy cell leukemia and factor VIII inhibitor: a case report. Nouv Rev Fr Hematol 1992 0.76
67 Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages. Ann Hematol 1992 0.76
68 Extramedullary acute promyelocytic leukemia. Cancer 1997 0.75
69 Unusual cytogenetic evolution in CML treated with interferon-alpha. Leukemia 1997 0.75
70 An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Cancer 1997 0.75
71 [Acute colonic pseudo-obstruction in acute promyelocytic leukemia]. Gastroenterol Clin Biol 1997 0.75
72 [Microvascularization of femoral bone marrow in the rabbit]. Arch Anat Histol Embryol 1971 0.75
73 [Comparative study of the regeneration of the microcirculation of rabbit femur bone marrow after curetage and at the time of experimental myelosclerosis]. C R Seances Soc Biol Fil 1977 0.75
74 [Extraskeletal plasma cell tumors (author's transl)]. Sem Hop 1979 0.75
75 [Hyperthyroidism and choriocarcinoma: a case]. Ann Med Interne (Paris) 1995 0.75
76 [Post-angiographic thorotrastosis and chronic agranulocytosis: ultrastructural examination of the bone marrow (author's transl)]. Nouv Rev Fr Hematol 1973 0.75
77 [Autoimmunity and deficiency of cell-mediated immunity in primary myelofibrosis]. Ann Immunol (Paris) 1977 0.75
78 [Lymphosarcoma of the duodenum. Apropos of a case]. Ann Chir 1967 0.75
79 Selective IgA deficiency and idiopathic thrombocytopenia. Ann Intern Med 1973 0.75
80 Delayed cutaneous hypersensitivity testing in untreated Hodgkin's disease using a standardized new device. Biomedicine 1980 0.75
81 Serum ferritin during the course of chronic myeloid leukemia. Increase of serum ferritin as a marker of dyserythropoiesis. Acta Haematol 1982 0.75
82 Cytopenias and anti-Ro (SS-A) antibodies: a report of 11 cases. Eur J Haematol 1990 0.75
83 [Lymph node toxoplasmosis: histo-serological correlations]. Nouv Presse Med 1979 0.75
84 Cytologic examination of broncho-alveolar fluid during the retinoic acid syndrome. Eur J Haematol 1996 0.75
85 [Mediastinal choriocarcinoma in acute myeloblastic leukemia]. Presse Med 1985 0.75
86 Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease. Ann Oncol 1997 0.75
87 [Clinical conference: Chronic myeloid leukemia, adenopathy and duplication of the Philadelphia chromosome. Extramedullary acuteness]. Nouv Rev Fr Hematol 1975 0.75
88 Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. Semin Oncol 1992 0.75
89 [Comparative double-blind study: alizapride-metoclopramide]. Ann Gastroenterol Hepatol (Paris) 1985 0.75
90 Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients. Prog Clin Biol Res 1990 0.75
91 [Hemolytic anemia caused by cisdiamino-dichloroplatinum. Lack of cross-reaction with carboplatin]. Presse Med 1990 0.75
92 Expression of CD44 spliced variants with both exons v9 and v10 in primary N(-)M(-) breast carcinomas correlates with metastasis. Int J Oncol 1997 0.75
93 [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)]. Nouv Presse Med 1979 0.75
94 [Toxicity of enzymes in acute pancreatitis. Clinical and experimental study]. Arch Fr Mal App Dig 1967 0.75
95 G6PD Vientiane: a new glucose-6-phosphate dehydrogenase variant with increased stability. Hum Genet 1978 0.75
96 [Variant Gd(-) "Strasbourg" of glucose-6-phosphate-dehydrogenase]. Nouv Rev Fr Hematol 1970 0.75
97 [Anti-pyocyanic and anti-staphylococcal vaccinations in malignant hemopathies]. Nouv Rev Fr Hematol 1976 0.75
98 [Experimental acute pancreatitis in rats and its histopathologic evolution in time. II. Acute pancreatitis induced with different enzymes: trypsin, alphachymotrypsin, elastase, collagenase and lipase]. Arch Fr Mal App Dig 1968 0.75
99 [Correlation between plasma ferritin and iron reserves in the aged subject]. Nouv Presse Med 1978 0.75
100 High dose intravenous IgG followed by splenectomy versus splenectomy alone in idiopathic thrombocytopenic purpura refractory to steroids. Nouv Rev Fr Hematol 1987 0.75
101 [Management of hematologic malignancies during pregnancy]. J Gynecol Obstet Biol Reprod (Paris) 1996 0.75
102 Ultrastructure of adipose tissue in the normal hematopoietic marrow of the rabbit. Pathol Biol (Paris) 1972 0.75
103 [High doses of alkylating agents and bone marrow autograft in ovarian cancer with poor prognosis: a retrospective analysis of 40 patients treated in France]. Bull Cancer 1990 0.75
104 [Splenectomies in chronic myeloid leukemia before acute transformation. Incidence of blastic meningitis]. Nouv Presse Med 1980 0.75
105 [Anemia caused by congenital dyserythropoiesis: type II (Hempas). Value of splenectomy]. Nouv Presse Med 1982 0.75
106 [Myelodysplastic syndromes]. Nouv Rev Fr Hematol 1991 0.75
107 Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effects. Oncol Rep 1998 0.75
108 [Fluorocarbons as blood substitutes. Toxicity in the rat]. Rev Fr Transfus Immunohematol 1979 0.75
109 Sister chromatid exchange and growth kinetics in chronic myeloid leukemia. Cancer Res 1982 0.75
110 [Moschcowitz's syndrome and severe digestive hemorrhage]. Sem Hop 1970 0.75
111 [Greenish blue man. Primary amyloidosis. Tyrosinuria]. Sem Hop 1972 0.75
112 [Extra-medullary megakaryocytes]. Nouv Rev Fr Hematol 1974 0.75
113 Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen. Hematol Oncol 1992 0.75
114 High-dose intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults. Blut 1984 0.75
115 [Hemolytic anemia induced by penicillin during agranulocytosis with plasmocytic reaction of the bone marrow. Apropos of a case. Review of the literature]. Sem Hop 1973 0.75
116 [Apropos of a series of 345 primary cancers of the colon and rectum. I. Therapeutic study. II. Comparison of histologic prognostic criteria]. Ann Chir 1966 0.75
117 [Comparative study of 4 strains of treponema by electron microscopy. Preliminary research]. Ann Dermatol Syphiligr (Paris) 1972 0.75
118 An in vitro study of the interactions of plasma proteins with protein A-sepharose CL4B chromatography columns used to remove immunoglobulin G from human plasma. Int J Artif Organs 1986 0.75
119 Letter: Implantation of fetal thymus during the terminal period of Hodgkin's disease. Immunologic and histological data. Nouv Presse Med 1975 0.75
120 [Breast osteosarcoma. Review of the literature and presentation of two cases]. Rev Fr Gynecol Obstet 1991 0.75
121 [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)]. Sem Hop 1979 0.75
122 [Experimental acute pancreatitis in rats and its histopathologic evolution in time. 3. Acute pancreatitis induced with trypsin inhibitors: zymofren and iniprol]. Arch Fr Mal App Dig 1968 0.75
123 An observation of neonatal reticulosis. Sacrez disease. Acta Paediatr Belg 1976 0.75
124 Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients. Infection 1991 0.75
125 [A new case of hemoglobin G Georgia (author's transl)]. Nouv Rev Fr Hematol 1976 0.75
126 Simultaneous determination of Pt and essential trace elements in plasma by energy dispersive x-ray fluorescence (EDXRF). J Trace Elem Electrolytes Health Dis 1987 0.75
127 Decreased "active" rosette-forming cells during remission in Hodgkin's disease. Biomedicine 1978 0.75
128 Hemopoietic bone culture in diffusion chambers. Biomedicine 1980 0.75
129 Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients. J Clin Oncol 2002 0.75
130 [Vascular regeneration of rabbit femoral bone marrow after curettage (author's transl)]. Arch Anat Histol Embryol 1974 0.75
131 [Relationships of factor VIII (antihemophilic globulin) and its weak inhibitors with the spleen. Effect of adrenaline on splenectomized subjects, on splenomegaly and on patients presenting a weak factor VIII inhibitor]. Haematol Lat 1971 0.75
132 The protection of hemopoietic mice progenitors by WR-2721 during photodynamic therapy. Nouv Rev Fr Hematol 1990 0.75
133 [Isoferritin profile of serum ferritin in patient's with secondary hemosiderosis treated with desferrioxamine]. Acta Haematol Pol 1983 0.75
134 Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use. Bone Marrow Transplant 1996 0.75
135 [Essential cysts of the kidney: histologic study]. J Urol Nephrol (Paris) 1967 0.75
136 [Use of stains in routine histopathology of semi-fine slices of "araldite" embedded bone marrow]. Nouv Rev Fr Hematol 1973 0.75
137 [Embolization of the foramen ovale in metastatic course of abdominal liposarcoma]. Ann Cardiol Angeiol (Paris) 1991 0.75
138 [Treatment using lymphocytapheresis of severe forms of Crohn's disease. Preliminary results]. Ann Med Interne (Paris) 1988 0.75
139 Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinity. Hum Genet 1995 0.75
140 PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease. Acta Haematol Pol 1977 0.75
141 [Hydrostatic hyperpressure and lymphocyte reactivity to phytohemmaglutinin]. C R Seances Soc Biol Fil 1974 0.75
142 Interferon enhanced natural killer function in Hodgkin's disease. Nouv Rev Fr Hematol 1986 0.75
143 [Pseudotumoral pneumocystosis: one case and a review of the literature]. Rev Pneumol Clin 1989 0.75
144 [Letter: Fatal neurologic complication after intraspinal methotrexate]. Nouv Presse Med 1976 0.75
145 [Blood coagulation disorders in massive blood transfusion]. Zentralbl Chir 1975 0.75
146 [Use of plastic isolators in the prevention of infection in high risk patients with hematologic diseases]. Sem Hop 1979 0.75
147 A T chronic lymphocytic leukemia with large granular lymphocytes. Phenotype and functions of leukemic cells under in vitro treatment by differentiation inducers. Cancer 1987 0.75
148 Intravenous ALS in the treatment of severe rectocolitis. N Engl J Med 1971 0.75
149 [Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]. Bull Cancer 1996 0.75
150 Trisomy 13 in a case of acute promyelocytic leukemia. Cancer Genet Cytogenet 1992 0.75
151 [Bone marrow microvascular changes in experimental myelosclerosis (author's transl)]. Nouv Rev Fr Hematol 1974 0.75
152 [Myelosclerosis : pseudo-tumors forms (author's transl)]. Nouv Rev Fr Hematol 1978 0.75
153 [Letter: Pseudo-viral intracytoplasmic inclusions in a case of acute lymphoid leukemia. Cytological, cytochemical and ultrastructural study]. Nouv Presse Med 1974 0.75
154 Normal active rosette-forming-cells in untreated patients with Hodgkin's disease. Biomedicine 1977 0.75
155 [Intraperitoneal treatment of tumors of the ovary]. J Gynecol Obstet Biol Reprod (Paris) 1991 0.75
156 Failure to obtain hybridomas between human macrophages and human tumoral U-937 cells is probably due to parental macrophages. In Vitro Cell Dev Biol Anim 1993 0.75
157 [A further case of circulating anticoagulant during myelosclerosis]. Nouv Rev Fr Hematol 1967 0.75
158 Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma. Leuk Lymphoma 1996 0.75
159 [Hypothyroid hypertrophic myopathy following mantle irradiation for Hodgkin's disease. A case]. Rev Med Interne 1991 0.75
160 [Reaming of the bone marrow in osteomyelosclerosis. Attempt at restoring normal erythropoiesis]. Nouv Rev Fr Hematol Blood Cells 1977 0.75
161 [Treatment with a piperacillin and netilmicin combination of patients with agranulocytosis]. Pathol Biol (Paris) 1988 0.75
162 High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease. Eur J Gynaecol Oncol 1991 0.75
163 [Apropos of certain toxic effects of L-asparaginase in human therapy]. Sem Hop 1971 0.75
164 [Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)]. Nouv Rev Fr Hematol 1981 0.75
165 Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma. J Clin Oncol 1998 0.75
166 [Osteogenic sarcoma of the breast. Literature review and a case report]. Tunis Med 1993 0.75
167 [Clinical conference: Myelosclerosis and chronic myeloid leukemia]. Nouv Rev Fr Hematol 1975 0.75
168 [Treatment of carcinomatous meningitis by continuous intrathecal infusion of methotrexate: 2 cases]. Ann Med Interne (Paris) 1995 0.75
169 [Farmer's lung with severe pulmonary hypertension]. Arch Mal Coeur Vaiss 1970 0.75
170 [Medullary microcirculation in human primary and secondary myeloscloroses]. Nouv Rev Fr Hematol 1976 0.75
171 Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study. Gynecol Oncol 1998 0.75
172 [Chronic erythroblastopenia. Therapeutic effect of androgens]. Nouv Rev Fr Hematol 1966 0.75
173 [Delayed cutaneous hypersensitivity in Hodgkin disease. Quantitative study using a new standardized system of multipunctures]. Presse Med 1983 0.75
174 Normal humoral immunity in hairy cell leukemia. Biomedicine 1976 0.75
175 [Auer bodies and Ph1 chromosome: chronic myeloid pseudoleukemia?]. Nouv Rev Fr Hematol 1982 0.75
176 [Maternal thrombopenia. Neonatal thrombopenia treated by exchange transfusion]. Nouv Rev Fr Hematol 1966 0.75
177 [Pseudo-tumor forms of myeloscleroses]. Nouv Rev Fr Hematol 1979 0.75
178 [Surgical correction of interventricular communication with pulmonary stenosis in a hemophiliac]. Arch Fr Pediatr 1983 0.75
179 [Application of the Spalteholtz technic to the study of microvascular regeneration of cureted hematopoietic marrow]. Nouv Rev Fr Hematol 1973 0.75
180 [Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase]. Nouv Presse Med 1974 0.75
181 [Vascularization of the human adult sternum (author's transl)]. Arch Anat Histol Embryol 1974 0.75
182 [Malignant myeloplax tumors]. Ann Anat Pathol (Paris) 1968 0.75
183 Decreased membrane "fluidity" of T lymphocytes from untreated patients with Hodgkin's disease. Leuk Res 1986 0.75
184 [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial]. J Urol (Paris) 1987 0.75
185 Immunomodulating effects of a short-term oral treatment with C 1821 in untreated cancer patients: a controlled study. Adv Exp Med Biol 1983 0.75
186 [Study of the reticulin in lymphoid syndromes of the bone marrow]. Nouv Rev Fr Hematol 1972 0.75
187 Chromosome analysis of spleen and/or lymph nodes of patients with chronic myeloid leukemia (CML). Blood 1978 0.75
188 [Chediak-Higashi syndrome. Study of lymphocyte transformation stimulated by phytohemaglutinin (PHA)]. Nouv Rev Fr Hematol 1976 0.75
189 Y chromosome duplication in chronic myeloid leukemia. Nouv Rev Fr Hematol 1982 0.75
190 [Modulation of adriamycin cytotoxicity on K 562 and K562adri cells by interferon alpha and/or all-trans-retinoic acid]. Bull Cancer 1994 0.75
191 Letter: Duplication of Philadelphia chromosome in acute transition of chronic granulocytic leukaemia. Ann Intern Med 1975 0.75
192 [Loss of cellular immunity during myelofibrosis]. Nouv Rev Fr Hematol Blood Cells 1977 0.75
193 Non-random clonal evolution in 45 cases of chronic myeloid leukemia. Leuk Res 1979 0.75
194 Mosaic 46,XY/92,XXYY,del(5)(q13 q34) in an adult lymphoblastic leukemia. Leuk Res 1991 0.75
195 [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)]. Pathol Biol (Paris) 1978 0.75
196 [Thoracic manifestations of leucosis and dysglobulinemia (apropos of 12 cases)]. J Fr Med Chir Thorac 1971 0.75
197 [Femoral bone marrow in myelosclerosis]. Nouv Rev Fr Hematol 1973 0.75
198 Enhancement of delayed cutaneous hypersensitivity in untreated cancer patients given a short-term oral treatment with C 1821. Cancer Immunol Immunother 1982 0.75
199 Peripheral blood CD34+ cells: method of purification and ex vivo expansion. Nouv Rev Fr Hematol 1995 0.75
200 [Cutaneous delayed hypersensitivity in breast cancer before therapy]. Presse Med 1983 0.75
201 [Cancer of the breast after Hodgkin's disease. Analysis of 6 cases]. Presse Med 1993 0.75
202 [Pseudo-acute surgical abdomen and acute leukemia]. Ann Chir 1998 0.75
203 [Intra-osseous pressure. I. Preliminary results]. Pathol Biol (Paris) 1972 0.75
204 [Letter: Cellular immunity and hairy cell leukemia]. Nouv Presse Med 1975 0.75
205 Sarcoidosis in a patient with cold haemagglutinin disease. Acta Haematol 1972 0.75
206 Hemolytic anemia and sulfhemoglobinemia due to phenacetin abuse: a case with multivisceral adverse effects. Clin Toxicol 1981 0.75
207 Are CD44 spliced variants involved in human breast cancer metastasis? Oncol Rep 2011 0.75
208 [Malignant nephroangiosclerosis with perithelial hyperplasia of glomerular arteriola]. Arch Anat Pathol (Paris) 1973 0.75
209 Establishment and characterization of somatic hybrids between human differentiated macrophages and mouse myeloma NS1 cells. Int J Cell Cloning 1990 0.75
210 Sodium diethyldithiocarbamate (imuthiol) and cancer. Adv Exp Med Biol 1983 0.75
211 Primary hepatic lymphoma associated with chronic hepatitis C. Ann Med Interne (Paris) 1997 0.75
212 Combination chemotherapy of malignant histiocytosis. Acta Haematol 1979 0.75
213 [Idiopathic thrombocytopenic purpura. Treatment by intravenous transfusion of polyvalent immunoglobulins]. Nouv Presse Med 1982 0.75
214 VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. Cancer Chemother Pharmacol 1989 0.75
215 [Study of the electroencephalographic and clinical correlations of sleep in cardiac patients]. Rev Neurol (Paris) 1966 0.75
216 [Lymphoplasmocytic lymphoma with monoclonal serum IgA in the development of dermatitis herpetiformis]. Nouv Presse Med 1981 0.75
217 [Experimental acute pancreatitis in rats and its histopathologic evolution in time. I. Acute pancreatitis induced with total pancreatic extract (pancrenase) and physiological serum]. Arch Fr Mal App Dig 1968 0.75